Loading clinical trials...
Loading clinical trials...
An Open Label, Randomized, Parallel Design Estimation Pilot Study to Compare the Effectiveness of 36 vs 48 Wks PegIntron Plus Ribavirin Treatment for HCV Patients Without Rapid Virologic Response(RVR) But With Undetectable HCV RNA at wk 8
Conditions
Interventions
Pegintron + Riba
Locations
5
Taiwan
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
Chang Gung Medical Foundation, Kaohsiung Branch
Kaohsiung City, Taiwan
Pingtung Christian Hospital
Pingtung City, Taiwan
Chi Mei Medical Center - Liouying Branch
Tainan, Taiwan
Shin Kong Wu Ho-Su Memorial Hosipital
Taipei, Taiwan
Start Date
August 1, 2011
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
September 12, 2012
NCT01866930
NCT02190305
NCT02333292
NCT02219503
NCT01704755
NCT00854087
Lead Sponsor
Chang Gung Memorial Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions